Carglumic acid
NDC 68475-006, Carglumic acid, tablet, for suspension, from Navinta LLC.
- Product NDC
- 68475-006
- Status
- Listed
- Labeler
- Navinta LLC
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213395
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68475-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARGLUMIC ACID200 mg/1
Pharmacologic classes
Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68475-006-01 | 68475000601 | 5 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01) |
| 68475-006-02 | 68475000602 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/59e73eb8-edf8-4fad-93c2-deb6b23497f8
Use it
Look up 68475-006 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68475-006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68475-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.